The best indicator for Leidos (LDOS)
We backtested 20 indicators across daily, weekly and hourly charts on real Leidos (LDOS) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
CCI
On the weekly chart, this is the strongest risk-adjusted edge we found for Leidos (LDOS) over ~19.7 years — trailing buy-and-hold by 1.4% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | CCI ✓ | Weekly | 7.8% | 0.53 | -23.4% | 80.0% | 20 | -1.4% |
| 2 | EMA 50/200 Cross ✓ | Daily | 6.7% | 0.4 | -42.3% | 28.6% | 14 | -2.5% |
| 3 | RSI Mean-Reversion ✓ | Daily | 3.6% | 0.36 | -31.7% | 74.2% | 31 | -5.5% |
| 4 | Heikin-Ashi Trend ✓ | Weekly | 5.1% | 0.36 | -62.4% | 45.1% | 182 | -4.0% |
| 5 | WaveTrend (8/6/4) ✓ | Weekly | 5.0% | 0.35 | -38.2% | 63.2% | 19 | -4.2% |
| 6 | Bollinger Mean-Reversion | Weekly | 3.9% | 0.33 | -37.9% | 75.0% | 16 | -5.2% |
| 7 | WaveTrend (8/6/4) ✓ | Daily | 4.4% | 0.32 | -37.5% | 68.1% | 72 | -4.8% |
| 8 | ADX / DMI ✓ | Daily | 3.3% | 0.3 | -48.4% | 52.5% | 120 | -5.8% |
| 9 | Money Flow Index ✓ | Daily | 3.7% | 0.3 | -40.8% | 63.2% | 19 | -5.5% |
| 10 | Holy Grail Confluence ✓ | Daily | 3.4% | 0.3 | -37.1% | 80.0% | 30 | -5.7% |
| 11 | Holy Grail Confluence ✓ | Weekly | 7.5% | 0.55 | -29.9% | 87.5% | 8 | -1.6% |
| 12 | Bollinger Mean-Reversion ✓ | Daily | 2.9% | 0.27 | -30.8% | 61.9% | 84 | -6.2% |
| 13 | Stochastic ✓ | Weekly | 3.0% | 0.26 | -38.7% | 72.2% | 18 | -6.1% |
| 14 | Donchian Breakout ✓ | Weekly | 3.0% | 0.25 | -55.3% | 47.1% | 17 | -6.1% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Leidos (LDOS), CCI on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.